Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
Nature Medicine1999Vol. 5(6), pp. 686–693
Citations Over TimeTop 1% of 1999 papers
Allan D. Kirk, Linda C. Burkly, D. Scott Batty, Roxanne E. Baumgartner, Justin D. Berning, K D Buchanan, John H. Fechner, Rhonda L. Germond, Robert L. Kampen, Noelle B. Patterson, S. John Swanson, Douglas K. Tadaki, Christopher TenHoor, Leonard White, Stuart J. Knechtle, David M. Harlan
Related Papers
- → CD40, but Not CD154, Expression on B Cells Is Necessary for Optimal Primary B Cell Responses(2003)81 cited
- → CD154/CD40-Mediated Expression of CD154 in Endothelial Cells: Consequences for Endothelial Cell–Monocyte Interaction(2004)72 cited
- → Increased Expression of CD40 Ligand in Activated CD4+T Lymphocytes of Systemic Sclerosis Patients(2000)44 cited
- → The CD154/CD40 Interaction Required for Retrovirus-Induced Murine Immunodeficiency Syndrome Is Not Mediated by Upregulation of the CD80/CD86 Costimulatory Molecules(2002)16 cited
- → CD40 on T cells interacts with CD154 to promote autoimmune diabetes (101.7)(2011)